The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Open accessAbstract
Comprehensive knowledge of the genomic alterations that underlie cancer is a critical foundation for diagnostics, prognostics, and targeted therapeutics. Systematic efforts to analyze cancer genomes are underway, but the analysis is hampered by the lack of a statistical framework to distinguish meaningful events from random background aberrations. Here we describe a systematic method, called Genomic Identification of Significant Targets in Cancer (GISTIC), designed for analyzing chromosomal aberrations in cancer. We use it to study chromosomal aberrations in 141 gliomas and compare the results with two prior studies. Traditional methods highlight hundreds of altered regions with little concordance between studies. The new approach reveals a highly concordant picture involving ≈35 significant events, including 16–18 broad events near chromosome-arm size and 16–21 focal events. Approximately half of these events correspond to known cancer-related genes, only some of which have been previously tied to glioma. We also show that superimposed broad and focal events may have different biological consequences. Specifically, gliomas with broad amplification of chromosome 7 have properties different from those with overlapping focal EGFR amplification: the broad events act in part through effects on MET and its ligand HGF and correlate with MET dependence in vitro. Our results support the feasibility and utility of systematic characterization of the cancer genome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Self-citationMolecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
Self-citationMalignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Characterizing the cancer genome in lung adenocarcinoma
Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105
Self-citationLi, C., & Hung Wong, W. (2001) · Genome Biology · doi:10.1186/gb-2001-2-8-research0032 · Cited by 976
Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00848.x · Cited by 740
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., Bulmer, S. E., Frank, D. A., Hahn, W. C., Sellers, W. R., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020313 · Cited by 677
Self-citationEkstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508776103 · Cited by 485
Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., Teague, J., Butler, A., Edkins, S., Stevens, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1855 · Cited by 469
Targeting the c-Met Signaling Pathway in Cancer
Peruzzi, B., & Bottaro, D. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0818 · Cited by 448
High-resolution genomic profiles of human lung cancer
Tonon, G., Wong, K.-K., Maulik, G., Brennan, C., Feng, B., Zhang, Y., Khatry, D. B., Protopopov, A., You, M. J., Aguirre, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504126102 · Cited by 394
Lee, J. C., Vivanco, I., Beroukhim, R., Huang, J. H. Y., Feng, W. L., DeBiasi, R. M., Yoshimoto, K., King, J. C., Nghiemphu, P., Yuza, Y., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030485 · Cited by 367
Self-citationCHD5 Is a Tumor Suppressor at Human 1p36
Bagchi, A., Papazoglu, C., Wu, Y., Capurso, D., Brodt, M., Francis, D., Bredel, M., Vogel, H., & Mills, A. A. (2007) · Cell · doi:10.1016/j.cell.2006.11.052 · Cited by 366
KRAUS, J. A., KOOPMANN, J., KASKEL, P., MAINTZ, D., BRANDNER, S., SCHRAMM, J., LOUIS, D. N., WIESTLER, O. D., & VON DEIMLING, A. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199501000-00011 · Cited by 349
Zhao, X., Weir, B. A., LaFramboise, T., Lin, M., Beroukhim, R., Garraway, L., Beheshti, J., Lee, J. C., Naoki, K., Richards, W. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4603 · Cited by 337
Self-citationStructure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors
Pedeutour, F., Forus, A., Coindre, J.-M., Berner, J.-M., Nicolo, G., Michiels, J.-F., Terrier, P., Ranchere-Vince, D., Collin, F., Myklebost, O., et al. (1999) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199901)24:1<30::aid-gcc5>3.0.co;2-p · Cited by 274
BindingDB (2025) · PubMed · doi:10.7270/q2dv1qm3 · Cited by 235
Mouse Models of Brain Tumors and Their Applications in Preclinical Trials
Fomchenko, E. I., & Holland, E. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0438 · Cited by 226
Degradation of the Met Tyrosine Kinase Receptor by the Ubiquitin-Proteasome Pathway
Jeffers, M., Taylor, G. A., Weidner, K. M., Omura, S., & Vande Woude, G. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.799 · Cited by 217
Maher, E. A., Brennan, C., Wen, P. Y., Durso, L., Ligon, K. L., Richardson, A., Khatry, D., Feng, B., Sinha, R., Louis, D. N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2072 · Cited by 210
Pathology and molecular genetics of astrocytic gliomas
Reifenberger, G., & Collins, V. P. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0564-x · Cited by 193
Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays
Beroukhim, R., Lin, M., Park, Y., Hao, K., Zhao, X., Garraway, L. A., Fox, E. A., Hochberg, E. P., Mellinghoff, I. K., Hofer, M. D., et al. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020041 · Cited by 158
Self-citationComment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"
Getz, G. A., Höfling, H., Mesirov, J. P., Golub, T. R., Meyerson, M. M., Tibshirani, R. J., & Lander, E. S. (2007) · Science · doi:10.1126/science.1138764 · Cited by 139
Self-citationKotliarov, Y., Steed, M. E., Christopher, N., Walling, J., Su, Q., Heiss, J. D., Rosenblum, M., Mikkelsen, T., Zenklusen, J. C., & Fine, H. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1691 · Cited by 127
Lipomas have characteristic structural chromosomal rearrangements of 12q13‐q14
Mandahl, N., Heim, S., Johansson, B., Bennet, K., Mertens, F., Olsson, G. O., Rööser, B., Rydholm, A., Willén, H., & Mitelman, F. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390605 · Cited by 92
Mellinghoff, I. K., Tran, C., & Sawyers, C. L. (2002) · PubMed · Cited by 88
Self-citationGene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.
Galanis, E., Buckner, J. C., Kimmel, D. W., Jenkins, R. B., Alderete, B. E., O'Fallon, J. R., Wang, C. H., Scheithauer, B. W., & James, C. D. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.717 · Cited by 76
Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"
Forrest, W. F., & Cavet, G. (2007) · Science · doi:10.1126/science.1138179 · Cited by 60
Takeyama, K., Monti, S., Manis, J. P., Cin, P. D., Getz, G. A., Beroukhim, R., Dutt, S., Aster, J. C., Alt, F. W., Golub, T. R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210650 · Cited by 32
Self-citation
Cited by
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
“Data Coordinating Center: Ari Kahn(13), Robert Sfeir(13), Jessica Chen(13), David Nassau(13), Larry Feng(13), Erin Hickey(13), Carl Schaefer(68), Subha Madhavan(68), Ken Buetow(68)”
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
“To confirm copy number events related to the subtypes, we used copy number data available for 43 samples in the validation set (Beroukhim et al., 2007).”
InfluentialSelf-citationComprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Metadata
- Authors
- Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., Du, J., Kau, T., Thomas, R. K., Shah, K., Soto, H., Perner, S., Prensner, J., Debiasi, R. M., Demichelis, F., Hatton, C., Rubin, M. A., Garraway, L. A., Nelson, S. F., Liau, L., Mischel, P. S., Cloughesy, T. F., Meyerson, M., Golub, T. A., Lander, E. S., Mellinghoff, I. K., & Sellers, W. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-12-11
- Volume
- 104
- Issue
- 50
- Pages
- 20007-20012
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2122769974
- Cited by
- 1,075
- References
- 37
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.